CYP26A1 and leukemia: Interestingly, since CYP26 is directly up-regulated by retinoids[42] in a variety of tissues including hepatocyte, intestine, endothelial cells and even leukemia[43], treatment with pharmacological doses of atRA could induce CYP26 expression by the BM niche and produce an even more protective microenvironment for LSCs.